Fan Liu is a venture capital investor at Sky9 Capital who previously co-founded and served as CEO of neoX Biotech, an AI-accelerated biologics discovery company that raised a $30M+ Series A from Sky9 and 5Y Capital. His background combines a Caltech PhD in computational chemistry, postdoctoral research at the Institute for Systems Biology, and hands-on experience leading AI-for-drug-discovery work before the field became mainstream, giving him direct founder empathy and technical depth that's uncommon among venture investors.
About their Fund
Sky9 Capital carries forward a multi-generational family legacy through its name tied to founding partner Ron Cao's grandfather "Yunjiu," the first in his family to study at Harvard, creating unusually personal branding for a VC firm that has raised around $2B across seven funds since 2011 with deep China tech pattern recognition from early backing major platforms like Meituan and Pinduoduo. The firm formalizes VC 3.0 through structured venture philanthropy including dedicated vehicles like the Good Soil Foundation and runs concrete Public Goods programs spanning technical fellowships, open-source grants, and a San Francisco pre-accelerator, positioning itself as a deliberate bridge between China and global markets across nine cities rather than just having multiple offices.
















.jpeg)







.jpeg)











































































.png)
























































































































.jpeg)









.jpeg)


















































































.jpeg)

